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doi:10.1016/j.jmii.2011.11.011Background and Purpose: Limited information is available regarding the role Panton-Valentine
leukocidin (PVL) plays in methicillin-susceptible Staphylococcus aureus (MSSA). In this study,
we compared the frequency of the PVL gene between MSSA strains isolated from patients with
MSSA infections and MSSA strains isolated from patients with evidence of MSSA nasal coloniza-
tion. We also explored the role that the PVL toxin plays in the ability of MSSA to cause disease
as well as the phylogenetic relationship between these S aureus strains.
Methods: The presence of MSSA strains was screened among children aged <18 years during
routine health maintenance visits and among children aged <7 years at daycare centers or
kindergartens during the 2003 to 2008 period. At the same time, clinical MSSA isolates were
recovered from patients with various types of bacterial infections. Polymerase chain reaction
was applied to detect the presence of the PVL and SEB genes in these strains. The strains were
also subjected to pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing
(MLST) studies. Clinical features were compared between patients with PVL-positive and those
with PVL-negative isolates.
Results: A total of 495 colonizing MSSA and 71 clinical MSSA isolates were used. The prevalence
of PVL-positive S aureus was significantly higher among clinical isolates than among colonizing
isolates (14/71, 19.7%; 5/495, 1.0%; p < 0.05). In addition, we found that patients with PVL-
positive MSSA infections had a significantly longer duration of fever and tended to have higher
C-reactive protein levels than patients with PVL-negative MSSA infections. MLST typing of the
19 PVL-positive MSSA isolates revealed ST59, a strain that is similar to the MLST type ofnt of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Number 325,
, Taipei, Taiwan.
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Panton-Valentine leukocidin in MSSA 209community-associated methicillin-resistant Staphylococcus aureus found in Taiwan. The PFGE
typing of PVL-positive/ST59 MSSA isolates revealed multiple pulsotypes.
Conclusion: The prevalence of the PVL gene was significantly higher among clinical strains of
MSSA (19.7%) than among colonizing strains (1.0%). In addition, patients infected with PVL-
positive MSSA strains had fever for a significantly longer duration and tended to have higher
C-reactive protein levels than patients with PVL-negative MSSA infections. Our findings imply
that PVL may play an important role in the pathogenesis of S aureus infection.
Copyright ª 2012, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Staphylococcus aureus plays an important role in various
infections including skin and soft tissue infections, pneu-
monia, bacteremia, meningitis and sepsis. Many community-
associated methicillin-resistant S aureus (CA-MRSA) strains
carry genes encoding Panton-Valentine leukocidin (PVL),
a bicomponent pore-forming cytotoxin that has been shown
to target polymorphonuclear cells, monocytes and macro-
phages in humans and rabbits.1 Clinically, PVL-producing S
aureus is primarily associated with skin and soft tissue
infections, such as furunculosis and skin abscesses, as well
as severe necrotizing community-acquired pneumonia.2e6
Recent studies have shown that PVL genes are commonly
detected among CA-MRSA strains that cause infection.7 In
fact, research has demonstrated that between 70% and
100% of CA-MRSA isolates that cause infection carry PVL
genes.8e11 The most common site of S aureus carriage is the
nose.12 The results of our previous study and those of other
studies conducted in Taiwan have also found that almost all
of the CA-MRSA strains that cause skin and soft tissue
infections, necrotizing pneumonia, and bone and joint
infections carry the PVL gene.13e21
The epidemiology and the pathogenic potential of PVL-
positive strains of methicillin-susceptible S aureus (MSSA)
are not well known in Taiwan. The proportion of MSSA
strains carrying the PVL gene has been reported to range
from 12% to 81%.22,23 In this study, we compared the
frequency of the PVL gene between MSSA strains isolated
from patients with MSSA infections and from patients with
evidence of MSSA nasal colonization. We also explored the
role that the PVL gene plays in the ability of MSSA to cause
disease and the phylogenetic relationship between these S
aureus strains. In our previous studies, high Staphylococcal
Enterotoxin B (SEB) gene carriage rate in S aureus was
noted.16,19 In this study, we wanted to find the definite
carriage rate of community-associated (CA)-MSSA in Taiwan.Methods
Study design and specimen collection
In this retrospective cohort study we evaluated all children
aged <18 years who presented to the Tri-Service General
Hospital (TSGH), Taipei, Taiwan during the period from
January 2003 to December 2008, with culture-proven
evidence of CA-MSSA infection. Non-duplicate CA-MSSAisolates were recovered from various clinical specimens
that had been obtained from patients who had sought
treatment in inpatient or outpatient wards. The definition
states that to be CA-MSSA, the infection must be diagnosed
in an outpatient or within 48 hours of hospitalization.
Patient characteristics and clinical information including
age, gender, underlying medical conditions, infection site
and type, dates of admission, discharge, last visit, clinical
course, duration of fever, white cell count, C-reactive
protein (CRP) level, and appropriateness of antibiotic
therapy were obtained from the patient medical records.
At the same time, to ascertain the circulation of S aureus in
nearby communities in Taipei, nasal swabs were collected
from the nares of infants and children aged 1 month to 6
years during health maintenance visits or physical exami-
nations at daycare centers or kindergartens with informed
consent.
Laboratory methods
Preparation of chromosomal DNA
S aureus was cultured in Muller Hinton agar medium and
stored in 20% glycerol containing trypticase soy broth at
70C. The isolates were confirmed as being S aureus by
colonial morphology, Gram staining, catalase activity and
coagulation of citrated rabbit plasma, using the Gentra
Puregene Bacteria Kit (Qiagen, Germany) for purification
and extraction of DNA.
Polymerase chain reaction
The presence of the lukS-PV and lukF-PV genes encoding
components of PVL was determined by a polymerase chain
reaction (PCR)-based method with the primer pair and
thermocycler conditions as previously described in Lina
et al.2 The expected size of the PVL gene product was 433
base pairs. Sequences specific for SEB were detected using
methods described by Jarraud et al.24 Positive and negative
controls were included in each assay.
Pulsed-field gel electrophoresis
Pulsed-field gel electrophoresis (PFGE) was performed
using the CHEF Mapper XA system (Bio-Rad Laboratories,
Hercules, CA, USA) according to a published protocol.25
Findings were interpreted on the basis of standard
criteria. The pulsotypes were designated in alphabetical
order. PFGE patterns with fewer than four band differences
from one existing pulsotype were defined as subtypes and
labeled with Arabic numbered suffixes.
Table 1 Annual distribution of PVL and SEB genes among
566 colonizing and clinical MSSA isolates
Year MSSA in healthy carriers
(N Z 495)
MSSA in patients with
infection (N Z 71)
PVL(þ) SEB(þ) PVL(þ) SEB(þ)
2003 3 19 7 7
2004 0 12 0 0
2005 0 1 1 1
2006 2 15 1 0
2007 0 5 1 0
2008 0 4 4 3
Total 5 56 14 11
MSSA Z methicillin-sensitive Staphylococcus aureus; PVL Z
Panton-Valentine leukocidin gene; SEB Z Staphylococcus
aureus enterotoxin B gene.
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analyzed using Molecular Analyst Fingerprinting, Finger-
printing Plus, and Fingerprinting DST software (Bio-Rad
Laboratories, Richmond, CA, USA). The grouping method
was performed to deduce a dendrogram from the matrix
using the unweighted pair group method, with the arith-
metic averages clustering technique after calculation of
similarities using the Pearson correlation coefficient
between each pair of organisms; the PFGE patterns were
distinguished at the 70% similarity level.
Multilocus sequence typing
The PVL-positive MSSA strains were studied using multilocus
sequence typing (MLST). MLST was performed by PCR
amplification and sequencing of housekeeping genes using
primers designed by Enright et al.26 Each sequence was
submitted to the MLST database website for assignment of
the allelic profile and sequence type (ST).
Statistical analysis
Statistical analyses were performed using the SAS statistical
package for Windows (Version 9.1, SAS Institute, NC, USA).
All categorical variables were compared by two-sided chi-
squared test Fisher’s exact test. Continuous variables were
compared by the Wilcoxon rank sum test. A p value of
<0.05 was defined as statistically significant.
Results
Population characteristics
A total of 495 nasal colonizing MSSA isolates were recovered
from 3305 infants and kindergarten children ranging in age
from 1 month to 6 years. Overall, a total of 71 non-
duplicate MSSA clinical isolates were cultured from
samples including blood (nZ 5, 7%), eye discharge (nZ 4,
5.6%), ear discharge (n Z 2, 2.8%), and purulent fluid
obtained from wounds, carbuncles, furuncles and cellulitis
wounds (n Z 60, 84.5%). The gender distribution and
median age were similar in both groups.
PVL and SEB toxins
The PVL gene was detected in five of the 495 colonizing S
aureus isolates (1%) and in 14 of the 71 clinical S aureus
isolates (19.7%). The prevalence of PVL-positive S aureus
was significantly higher among clinical isolates than among
colonizing isolates (5/495, 1.0% versus 14/71, 19.7%;
p < 0.05). On the other hand, the SEB gene was detected in
56 of the 495 colonizing S aureus isolates (11.3%) and in 11
of the 71 clinical S aureus isolates (15.5%). There was no
significant difference in prevalence of the SEB gene
between the two groups of children. Only three out of five
PVL-positive colonizing strains (60%) carried the SEB gene;
whereas 10 of 14 PVL clinical strains (71.4%) harbored the
SEB gene (Table 1).
The role of PVL toxin in clinical infection
The second part of the study compared the differences in
clinical manifestations between patients with PVL-positiveand patients with PVL-negative MSSA strains. We found that
patients with PVL-positive MSSA infections had a fever for
a significantly longer time and tended to have higher CRP
levels than patients with PVL-negative MSSA infections.
There were no significant differences in age, gender or
duration of hospitalization between the two groups. In
addition, there were no significant differences in major
sites of infection between the two groups. Furthermore,
there were no significant differences in white blood cell
counts, treatment counts, treatment with incision and
drainage, or duration of hospitalization between the two
groups (Table 2).
MLST typing
MLST typing of the PVL-positive MSSA isolates revealed that
all of the PVL-positive MSSA strains were ST59, which is
similar to the major MLST type of CA-MRSA found in Taiwan.
PFGE typing
PFGE typing revealed a wide diversity of pulsotypes among
the 19 MSSA strains (Fig. 1). Three clusters, which included
13 (68.4%) strains, were distinguished at the 70% similarity
level. Pulsotype A (three subtypes) was the most common
and accounted for two (40%) of the five colonizing strains
and four (28.6%) of the 14 clinical strains. Pulsotype C
(two subtypes) was detected in one clinical stain and one
colonizing strain. It was indistinguishable from TSGH-17,
which is a prototype of CA-MRSA; ST59/PFT USA1000/PVL
(þ)/SCCmecVT.27
Discussion
The epidemiology of PVL-positive MSSA is not well known
and the pathogenic potential is probably underestimated.
The proportion of MSSA strains containing the PVL gene has
been reported to range from 12% to as high as 81%.22,23
Some animal studies have suggested that PVL is a major
virulence determinant.5,28 In addition, the PVL gene has
been reported to be more common in MRSA than in MSSA
isolates.1,17e21
Table 2 Demographic and clinical characteristics of 71 children with MSSA infection
Variable Number of patients P value
PVL(-) patients (n Z 57) PVL(þ) patients (n Z 14)
Demographic information
Age, median months (range) 62 month (1de17y) 80 month (5me16y) 0.5531
Sex, M:F (ratio) 1.59 (35:22) 3.6 (11:3) 0.3507
OPD/admission 22/35 7/7 0.4367
Clinical diagnosis
Bacteremia 5/57 (8.8%) 0/14 (0%) 0.2036
Conjunctivitis 4/57 (7%) 0/14 (0%)
Otitis media with discharge 1//57 (1.8%) 1/14 (7.1%)
Scarlet fever 6/57 (10.5%) 2/14 (14.3%)
Skin and soft tissue infection (carbuncle, cellulites) 41/57 (71.9%) 11/14 (78.6%)
Infection site
Thigh 21/57 (36.8%) 7/14 (50%) 0.2028
Head and neck 6/57 (10.5%) 3/14 (21.5%)
Buttock 3/57 (5.3%) 2/14 (14.3%)
Trunk 18/57 (31.6%) 1/14 (7.1%)
Others (blood, ear, eye discharge) 9/57 (15.8%) 1/14 (7.1%)
Laboratory findings*
WBC count, median cells _ 103/mm3 (range) 9950 (3900e20,930) 10,100 (5900e39,200) 0.6279
CRP level, median mg/dL (range) 0.64 (0.04e11.93) 2.64 (0.06e28.7) 0.0795
Treatment and outcome*
Antibiotic treatment 31/35 (88.6%) 7/7 (100%) 0.9999
No active antibiotic 4/35 (11.4%) 0/7 (0%)
Incision and drainage 10/35 (28.6%) 3//7 (42.9%) 0.6567
No incision and drainage 25/35 (71.4%) 4/7 (57.1%)
Duration of fever after antibiotic, median days (range) 1.00 (0e19) 5.00 (1e26) 0.0083a
Total hospital stay, median days (range) 5.00 (1e28) 6.00 (3e29) 0.5617
NOTE. Data are number (%) of patients, unless otherwise indicated. CRP Z C-reactive protein, MSSA Z methicillin-sensitive Staphy-
lococcus aureus, MRSA Z methicillin-resistant S. aureus, OR Z odds ratio, WBC Z white blood cell. CRP levels were determined for
patients.* 42 admission patients profiles.
a Statistically significant association after analysis (p < 0.05). All categorical variables were compared by two-sided chi-squared or
Fisher’s exact tests. Continuous variables were compared using the Wilcoxon rank sum test.
Panton-Valentine leukocidin in MSSA 211In the present study, nasal colonization of MSSA was
found in 495 (15%) of the 3305 children tested; a finding
that is consistent with data in our previous report con-
ducted during 2004 to 2009, which showed that the prev-
alence of nasal colonization by MSSA was 14.2%.19
In our previous study16 we found that 71.4% of clinical
MSSA isolates and 60% of colonizing MSSA isolates harbored
the SEB gene; whereas 100% of the CA-MRSA strains carried
the gene. The findings in this study, which show that the
SEB gene had high carriage rate by S aureus in Taiwan,
support the findings reported in numerous studies.13,16e21
Previous studies in Taiwan have found that ST59 MRSA
isolates are the most common causes of community-
associated infections and are the most frequently found
isolates in nasal colonization.13e21 In this study, molecular
analysis indicated that all PVL-positive MSSA colonizing and
clinical isolates had the same ST59 type. This means that
there is a strong association between ST59 CA-MRSA clinical
strains and community-associated ST59 MSSA strains.
The PVL toxin plays an important role in inflammatory
response and is known to be involved in the development of
some diseases, such as skin and soft tissue infection andnecrotizing pneumonia.2e4 Our study showed that only
19.7% of clinical MSSA isolates harbored the PVL gene, and
only 1% of colonizing isolates were PVL-positive. This
finding is similar to that in our previous study16 which
showed that almost all clinical CA-MRSA isolates were PVL-
positive, whereas only 16.9% of colonizing strains contained
the PVL gene. The prevalence of the PVL gene was higher in
CA-MRSA isolates than in MSSA isolates and was higher in
clinical isolates than in colonization isolates. The finding
suggests that the PVL gene plays an important role in the
pathogenesis of S aureus infections.
To the best of our knowledge, this is the first case series
to compare the distribution of PVL-positive and -negative
genotypes in children with MSSA infections in Taiwan. In our
univariate analysis, we found that only longer duration of
fever and higher CRP levels were associated with PVL-
positive clinical MSSA isolates; whereas in our previous
study of CA-MRSA strains that caused staphylococcal scarlet
fever,18 PVL-positive isolates were associated with signifi-
cantly larger abscess sizes, higher white blood cell counts,
higher CRP levels, longer duration of fever, generalized
rash and longer hospital stay.
Figure 1. Characterization of 19 PVL-positive MSSA clinical or colonization strains, which were classified into nine pulsotypes.
TSGH-17 was a prototype ST59/PFT USA1000 SCCmecVT CA-MRSA strain.
212 Y.-K. Chiu et al.PFGE revealed one clinical strain and one colonizing
strain of MSSA that were indistinguishable from TSGH-17,
which is a prototype of CA-MRSA (ST59/PFT USA1000/PVL
(þ)/SCCmecVT) circulating in Taiwan. We hypothesize that
the PVL gene might have been independently integrated
into the genomes of many different ancestral MSSA clones,
including ST59 MSSA. The ST59 MSSA strains might then have
transformed into PVL-positive ST59 MSSA strains. After
that, a few of the most evolutionarily successful PVL-
positive ST59 MSSA strains might have received a small
cassette conferring methicillin resistance (mecA gene) for
a successful transition to an CA-MRSA genotype comprising
the Staphylococcal Cassette Chromosome mec (SCCmec)
and the PVL gene.
The prevalence of the PVL gene was significantly higher
among clinical strains of MSSA (19.7%) than colonizing
strains (1%). Patients infected with PVL-positive MSSA
strains had significantly longer durations of fever and ten-
ded to have higher CRP levels than patients with PVL-
negative MSSA infections. Our findings imply that PVL may
play a role in the pathogenesis of S aureus infection.
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